Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial Board332
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch166
Endometriosis and autoimmunity156
Susac syndrome: A scoping review131
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective122
“Fibromyalgia syndrome” related to Essure devices106
Editorial Board99
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders97
Leflunomide: A safe and effective alternative in systemic lupus erythematosus92
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance88
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases86
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management86
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis84
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis81
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review80
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence77
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives77
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)75
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 2473
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction73
Psychiatric manifestations of autoimmune encephalitis72
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy68
Can anticoagulation be withdrawn in APS patients after aPL negativization?67
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes64
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease61
Editorial Board58
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology 58
STING-inflammasome axis in autoimmune diseases and inflammation-related disease55
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis54
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered53
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature50
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate50
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases48
Seronegative autoimmune diseases: A challenging diagnosis47
Autoimmunity in vitiligo: Therapeutic implications and opportunities47
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases47
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination47
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy47
Autoimmune pre-disease46
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 202146
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review45
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis45
Editorial Board45
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.45
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium44
0.21619200706482